Latest Payments News

BOD Science has executed an asset sale deed transferring critical intellectual property rights to Optimus Salvus, marking a pivotal step in its Deed of Company Arrangement process.

Supply Network Limited projects a solid half-year profit of $19.8 million and announces a fully franked interim dividend of 32.0 cents per share, signaling steady financial health ahead of its full results.

Supply Network Limited has announced a fully franked ordinary dividend of AUD 0.32 per share, payable on April 4, 2025, alongside a Dividend Reinvestment Plan offering a 2.5% discount for shareholders.

Merchant House International Limited reports the completion of its Tianjin asset sale and the cessation of AMI operations, signaling a strategic wind-up and delisting plan.

360 Capital Mortgage REIT has announced an estimated ordinary dividend of AUD 0.052 per unit for January 2025, alongside its election to adopt the Attribution Managed Investment Trust (AMIT) regime.

Perpetual Credit Income Trust has announced an estimated ordinary dividend of AUD 0.00686177 per unit for the month ending January 31, 2025, with a Dividend Reinvestment Plan available to investors.

Gladiator Resources reports strong assay results supporting high-grade uranium intersections at its Mkuju Project, with promising extensions identified at Likuyu North. The company also advances exploration at its Eland Project while maintaining a solid cash position.

Multistack International Limited reported a net cash outflow from operating activities of $72,916 for the December 2024 quarter but ended with robust cash reserves of $975,608. Despite ongoing negative cash flows, the company remains confident in sustaining operations through secured financing and strategic asset acquisitions.

Pengana Private Equity Trust has updated the Dividend Reinvestment Plan (DRP) price for its upcoming ordinary distribution, maintaining a steady payout of AUD 0.03176 per unit for the half-year ending December 2024.

Spacetalk Ltd reports robust growth in paid mobile subscribers and annual recurring revenue for Q2 FY25, underpinned by strategic international expansion and disciplined cost management.

Respiri Limited reports a standout December quarter marked by a 67% surge in patient program enrolments and robust revenue growth, bolstered by strategic acquisition synergies from Orb Health. The company is poised for further expansion in 2025 amid promising contract negotiations and evolving US healthcare reimbursement policies.

Biotron Limited has engaged US-based C14 Consulting Group to drive strategic partnerships for its antiviral drug portfolio, including lead candidate BIT225, while advancing its Hepatitis B research.